3-191218788-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_198184.2(OSTN):āc.144A>Gā(p.Thr48=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0097 in 1,614,078 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0070 ( 8 hom., cov: 32)
Exomes š: 0.010 ( 87 hom. )
Consequence
OSTN
NM_198184.2 synonymous
NM_198184.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.234
Genes affected
OSTN (HGNC:29961): (osteocrin) Predicted to enable signaling receptor binding activity. Involved in negative regulation of dendrite extension. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-191218788-A-G is Benign according to our data. Variant chr3-191218788-A-G is described in ClinVar as [Benign]. Clinvar id is 775208.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.234 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSTN | NM_198184.2 | c.144A>G | p.Thr48= | synonymous_variant | 3/5 | ENST00000682035.1 | NP_937827.1 | |
OSTN-AS1 | NR_133663.1 | n.355+28T>C | intron_variant, non_coding_transcript_variant | |||||
OSTN | XM_017006303.3 | c.144A>G | p.Thr48= | synonymous_variant | 3/5 | XP_016861792.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSTN | ENST00000682035.1 | c.144A>G | p.Thr48= | synonymous_variant | 3/5 | NM_198184.2 | ENSP00000508312 | P1 | ||
OSTN-AS1 | ENST00000430375.1 | n.355+28T>C | intron_variant, non_coding_transcript_variant | 5 | ||||||
OSTN | ENST00000445281.5 | c.144A>G | p.Thr48= | synonymous_variant | 3/4 | 5 | ENSP00000416576 |
Frequencies
GnomAD3 genomes AF: 0.00702 AC: 1068AN: 152188Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
1068
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00906 AC: 2277AN: 251198Hom.: 22 AF XY: 0.00977 AC XY: 1326AN XY: 135748
GnomAD3 exomes
AF:
AC:
2277
AN:
251198
Hom.:
AF XY:
AC XY:
1326
AN XY:
135748
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00998 AC: 14584AN: 1461772Hom.: 87 Cov.: 31 AF XY: 0.0100 AC XY: 7299AN XY: 727186
GnomAD4 exome
AF:
AC:
14584
AN:
1461772
Hom.:
Cov.:
31
AF XY:
AC XY:
7299
AN XY:
727186
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00701 AC: 1067AN: 152306Hom.: 8 Cov.: 32 AF XY: 0.00724 AC XY: 539AN XY: 74484
GnomAD4 genome
AF:
AC:
1067
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
539
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 13, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at